224 related articles for article (PubMed ID: 32467608)
21. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
[No Abstract] [Full Text] [Related]
22. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
Xie C; Guo Y; Lou S
Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
[TBL] [Abstract][Full Text] [Related]
23. A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.
Minotti L; Baldassari F; Galasso M; Volinia S; Bergamini CM; Bianchi N
Amino Acids; 2018 Apr; 50(3-4):421-438. PubMed ID: 29313085
[TBL] [Abstract][Full Text] [Related]
24. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
Cao J; Huang W
PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
[TBL] [Abstract][Full Text] [Related]
25. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
26. The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer.
Wang H; Zhang J; Wei Z; Chen S; Zheng J; Li Y
Front Immunol; 2024; 15():1364979. PubMed ID: 38812506
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications.
Rihawi K; Ricci AD; Rizzo A; Brocchi S; Marasco G; Pastore LV; Llimpe FLR; Golfieri R; Renzulli M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916915
[TBL] [Abstract][Full Text] [Related]
28. Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
Brown KD
Breast Cancer Res Treat; 2013 Jan; 137(2):329-36. PubMed ID: 23224146
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.
Yamaguchi H; Kuroda K; Sugitani M; Takayama T; Hasegawa K; Esumi M
Int J Oncol; 2017 May; 50(5):1749-1759. PubMed ID: 28339069
[TBL] [Abstract][Full Text] [Related]
30. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
J Exp Clin Cancer Res; 2018 Jan; 37(1):13. PubMed ID: 29374493
[TBL] [Abstract][Full Text] [Related]
31. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Li C; Cai J; Ge F; Wang G
Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
[TBL] [Abstract][Full Text] [Related]
32. Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
Thangaraju K; Király R; Demény MA; András Mótyán J; Fuxreiter M; Fésüs L
PLoS One; 2017; 12(3):e0172189. PubMed ID: 28248968
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional control of transglutaminase 2 expression in mouse apoptotic thymocytes.
Sándor K; Daniel B; Kiss B; Kovács F; Szondy Z
Biochim Biophys Acta; 2016 Aug; 1859(8):964-74. PubMed ID: 27262403
[TBL] [Abstract][Full Text] [Related]
34. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes.
Hallstrand TS; Wurfel MM; Lai Y; Ni Z; Gelb MH; Altemeier WA; Beyer RP; Aitken ML; Henderson WR
PLoS One; 2010 Jan; 5(1):e8583. PubMed ID: 20052409
[TBL] [Abstract][Full Text] [Related]
35. Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.
Huang YC; Wei KC; Chang CN; Chen PY; Hsu PW; Chen CP; Lu CS; Wang HL; Gutmann DH; Yeh TH
PLoS One; 2014; 9(9):e108228. PubMed ID: 25247996
[TBL] [Abstract][Full Text] [Related]
36. Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer Cells.
Zhou Y; Xia L; Liu Q; Wang H; Lin J; Oyang L; Chen X; Luo X; Tan S; Tian Y; Su M; Wang Y; Chen P; Wu Y; Wang H; Liao Q
Cell Physiol Biochem; 2018; 47(4):1399-1410. PubMed ID: 29929193
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
38. Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation.
Yeo SY; Itahana Y; Guo AK; Han R; Iwamoto K; Nguyen HT; Bao Y; Kleiber K; Wu YJ; Bay BH; Voorhoeve M; Itahana K
Elife; 2016 Mar; 5():e07101. PubMed ID: 26956429
[TBL] [Abstract][Full Text] [Related]
39. Tissue transglutaminase is involved in mechanical load-induced osteogenic differentiation of human ligamentum flavum cells.
Chao YH; Huang SY; Yang RC; Sun JS
Connect Tissue Res; 2016 Jul; 57(4):307-18. PubMed ID: 27115725
[TBL] [Abstract][Full Text] [Related]
40. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Ai L; Kim WJ; Demircan B; Dyer LM; Bray KJ; Skehan RR; Massoll NA; Brown KD
Carcinogenesis; 2008 Mar; 29(3):510-8. PubMed ID: 18174247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
